Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: Intravenous Ferric carboxymaltose: 1)Women with Hemoglobin (Hb) levels ranging from 7 gm/dL to 9.9gm/dL on day 2 of post-partum period, will be administered Ferric Carboxymaltose (FCM)
Sponsors
Dr Samreen Mirza
Eligibility
Inclusion criteria
Inclusion criteria: 1)Women after 2 days of delivery with postpartum anemia 2)Hemoglobin values between 7gm/dl to 10 gm/dl 3)Women who had received blood for severe anemia in post partum period will also be included, if there Hb is below 10gm/dl. 4)Women already on oral hematinics will also be considered in the study which will act as adjunct along with Inj. Ferric Carboxymaltose.
Exclusion criteria
Exclusion criteria: 1)Diagnosed anemia like thalassemia, sickle cell anemia, etc. 2)Current treatment with myelosuppressive therapy. Bleeding disorders. 3)Hypersensitivity to IV iron compounds 4)Chronic liver and kidney disorders. 5)Iron overload states, for example, hemosiderosis or hemochromatosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To estimate the efficacy of intravenous ferric carboxy maltose in treatment of postpartum anemia 2)To correlate Hb levels, RBC indices and peripheral smear before and after administration of intravenous ferric carboxymaltose and at 1 month & 3 months. Timepoint: Hemoglobin levels, RBC indices and peripheral smear before and after administration of intravenous ferric carboxymaltose and at 1 month & 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr. Samreen Mirza
D.Y PATIL HOSPITAL AND RESEARCH CENTRE
Outcome results
None listed